Exelixis

Revolution Medicines

Gilead Sciences

Incyte

Rogers

Arcellx

Banco Santander

Sarepta Therapeutics

GlaxoSmithKline

Regeneron Pharmaceuticals

iShares Genomics Immunology and Healthcare ETF

IDNA tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering.

iShares Nasdaq Biotechnology ETF

While biotech stocks are often too risky for many investors, with the coronavirus raging and the race for a vaccine in play, taking a look at some ETFs that contain biotech stocks that are making strides might not be such a bad idea.

2 Biotechnology ETFs That Could Be Good For Diversification

ARK Genomic Revolution Multi-Sector ETF

Aytu BioScience

VanEck Vectors Biotech ETF

Loncar Cancer Immunotherapy ETF

Co-Diagnostics

Forty Seven Inc

Vir Biotechnology

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

Coronavirus Scare Supports These Biotech ETFs & Stocks

ProShares Long Online/Short Stores ETF

SPDR Wells Fargo Preferred Stock ETF

An oil collapse sent Wall Street into a tailspin on Mar 9, indicating that the 11-year-long bull market might soon end. These ETFs may, however, survive the crash.

11-Year Bull Market Nears an End? ETFs That Should Survive

SPDR Gold Trust

KraneShares MSCI All China Health Care Index ETF

Sprott Gold Miners ETF

These sector ETFs gained or lost the least in the coronavirus-induced rout in February.

Wall Street in Correction: 4 Sector ETFs Unscathed in February

Virtus LifeSci Biotech Clinical Trials ETF

ROBO Global Healthcare Technology and Innovation ETF

Invesco Dynamic Biotechnology & Genome ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Biotech ETF

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

News for iShares Genomics Immunology and Healthcare ETF ETF (IDNA)